Gastric Mucin EINECS 282-010-7 EINECS 282-010-7
1. Product advantages
High purity, all above 98.5%, no impurities after dissolution
We will test each batch to ensure quality
OEM and private brand services designed for free
Various cap colors available
We can also provide MT1 peptide powder
2. Factory advantages
Professional research team
More than 5 doctors in high-tech R&D laboratories
More than 1000 m2 of factory production line to ensure stable supply
More than 1200 factories to manufacture products and control quality
3. Service advantages
24-hour online service
Track package information and update it for customers
Professional sales team
Accept small order service
Redelivery service if detained by customs
Product Introduction:
Gastric mucin is a large glycoprotein that protects the gastrointestinal tract from the effects of acids, proteases, pathogenic microorganisms, and mechanical trauma.
Related categories
Signal Path>>Other>>Other
Research Fields>>Metabolic Diseases
Peptide products
In vitro research on gastric mucin may be related to the mechanism of gastric mucosal damage caused by Helicobacter pylori, leading to gastritis, peptic ulcers, and possibly gastric cancer. Gastric mucins are divided into two categories based on their histochemical properties. The first type is surface mucus cell type mucin, secreted by surface mucus cells. The second type is found in the deeper part of the mucosa, secreted by glandular mucus cells, including mucinous neck cells, cardiac gland cells, and pyloric gland cells. The unique O-glycan in gastric mucin seems to act as a natural antibiotic, protecting the host from Helicobacter pylori infection. Gastric mucin can protect the surface epithelium of the gastrointestinal tract by clearing oxidants produced within the cavity; However, it comes at the cost of sacrificing its viscoelasticity. Both natural and streptoprotease treated mucins effectively scavenge hydroxyl radicals, and there was no significant difference in their scavenging properties. For natural and streptoprotease treated mucins, the effective concentration of mucin required to reduce malondialdehyde production by 50% is 10 mg/mL.
CAS NO:27813-02-1
CAS NO:2113-05-5
CAS NO:57-85-2
CAS NO:49851-31-2
CAS NO:102-97-6
CAS NO:315-30-0
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View